Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.63 |
| ▸ | TK2 | O00142 | 8/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TK1 | P04183 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17583354 | 0.91 | TK1 (0.53) | TYMPTK2MAPK1TK1 | |
| SCHEMBL17583278 | 0.79 | TYMP (0.54) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL8780707 | 0.79 | TYMP (0.61) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL3854773 | 0.77 | TYMP (1.00) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL6153435 | 0.77 | TYMP (0.66) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL30903369 | 0.75 | TYMP (0.60) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL23453029 | 0.75 | TYMP (0.59) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL15110503 | 0.74 | TK2 (0.60) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL17013820 | 0.73 | MAPK1 (0.54) | TYMPTK2MAPK1HPGDTK1 | |
| SCHEMBL24322118 | 0.73 | TYMP (0.54) | TYMPTK2MAPK1HPGDTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10745570-B2 | Copper-containing articles | EASTMAN RODACK COMPANY (US) | 2020-08-18 | — | — | US | disclosed |
| US-20190233660-A1 | COPPER-CONTAINING ARTICLES | BANK OF AMERICA, N.A., AS AGENT | 2019-08-01 | — | — | US | disclosed |
| US-9963614-B2 | Copper-containing articles and methods for providing same | EASTMAN KODAK COMPANY (US) | 2018-05-08 | — | — | US | disclosed |
| US-20160338358-A1 | COPPER-CONTAINING POLYMERIC COMPOSITIONS | KODAK AMERICAS, LTD. | 2016-11-24 | — | — | US | disclosed |
| US-20160340540-A1 | COPPER-CONTAINING ARTICLES AND METHODS FOR PROVIDING SAME | BANK OF AMERICA, N.A., AS AGENT | 2016-11-24 | — | — | US | disclosed |
| US-9360759-B2 | Forming conductive metal patterns using water-soluble polymers | EASTMAN KODAK COMPANY (US) | 2016-06-07 | — | — | US | disclosed |
| US-20160077438-A1 | FORMING CONDUCTIVE METAL PATTERNS USING WATER-SOLUBLE POLYMERS | BANK OF AMERICA, N.A., AS AGENT | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160338358-A1 | COPPER-CONTAINING POLYMERIC COMPOSITIONS | CCNC, CTR9, PPOX | TYMP 1235/4885TK2 2034/4885MAPK1 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.